6-(甲氧基甲基)-1,2,3,4-四氢萘 | 112504-94-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 中文名称: 6-(甲氧基甲基)-1,2,3,4-四氢萘
• 英文名称: 6-methoxymethyl-1,2,3,4-tetrahydronaphthalene
• 英文别名: 6-Tetralylmethyl-methyl-ether；methyl-(5,6,7,8-tetrahydro-[2]naphthylmethyl)-ether；Methyl-(5,6,7,8-tetrahydro-[2]naphthylmethyl)-aether；2-Methoxymethyl-5.6.7.8-tetrahydro-naphthalin；6-Methoxymethyl-tetralin；6-(Methoxymethyl)-1,2,3,4-tetrahydronaphthalene
• CAS: 112504-94-6
• 化学式: C₁₂H₁₆O
• 分子量: 176.258
• InChiKey: BFMFIVRTCVGWKU-UHFFFAOYSA-N

物化性质

• 沸点：
  258.4±9.0 °C(Predicted)
• 密度：
  1.004±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  6-羟甲基-1,2,3,4-四氢萘 在 氯化亚砜 作用下， 以 苯 为溶剂， 生成 6-(甲氧基甲基)-1,2,3,4-四氢萘
  参考文献：
  名称：

  Aromatische Spirane, 16. Mitt.: Darstellung von monound dianellierten 2,2?-Spirobiindan-1,1?-dionen

  摘要：

  DOI：

  10.1007/bf00810848

文献信息

• Aryl Annulation of Cyclic Ketones via a Magnesium Carbometalation−6-π- Electrocyclization Protocol
  作者：Pierre E. Tessier、Natalie Nguyen、Matthew D. Clay、Alex G. Fallis

  DOI：10.1021/ol047602y

  日期：2005.3.1

  annulation of cyclic ketones is described. Palladium(0) coupling of a propargyl alcohol with the enol triflate of a ketone and addition of vinylmagnesium chloride generates a triene as a magnesium chelate that may be quenched with an electrophile. In some cases, the triene cyclizes under the reaction conditions. Aromatization is accomplished by exposure to manganese dioxide or dichlorodicyanoquinone

  描述了环酮芳基环化的新策略。炔丙醇与酮的三氟甲磺酸酯的钯（0）偶联以及乙烯基氯化镁的添加生成三烯作为镁螯合物，可以用亲电子体将其淬灭。在某些情况下，三烯在反应条件下环化。芳香化是通过暴露于二氧化锰或二氯二氰基醌（DDQ）来完成的。[反应：看文字]
• [EN] 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS<br/>[FR] COMPOSES 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE POUR LE TRAITEMENT DE LA TUBERCULOSE
  申请人：OTSUKA PHARMA CO LTD

  公开号：WO2005042542A1

  公开（公告）日：2005-05-12

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1)in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and -(CH2)nR2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30)and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.

  本发明提供了一种由以下一般式表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物：(1)在上述式(1)中，R1代表氢原子或C1-C6烷基，n代表0至6的整数，R1和-(CH2)nR2可以与下面的式(30)一起形成一个螺环，与相邻的碳原子一起（在下面的式中，RRR代表可能在哌啶环上具有取代基的哌啶基），(30)和R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似物。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型耐酸细菌具有出色的杀菌作用。
• 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis
  申请人：Tsubouchi Hidetsugu

  公开号：US20080119478A1

  公开（公告）日：2008-05-22

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1) in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and —(CH2) n R2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30) and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.

  本发明提供了一种由下述通式（1）表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物： 在上述式（1）中，R1代表氢原子或C1-C6烷基，n代表0到6的整数，R1和—(CH2)nR2可以与相邻的碳原子形成如下式（30）所示的螺环，其中，在下式中，RRR代表可能在哌啶环上具有取代基的哌啶基： （30）且R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似基团。该化合物对结核分枝杆菌、多重耐药结核分枝杆菌和非典型酸杆菌具有优异的杀菌作用。
• SUBSTITUTED BENZOXAZOLES AND METHODS OF USE THEREOF
  申请人：CHOWDHURY Sultan

  公开号：US20160009667A1

  公开（公告）日：2016-01-14

  The invention provides compounds having the general formula (I): and pharmaceutically acceptable salts thereof, wherein the variables RA, subscript n, ring A, X 2 , L, subscript m, X 1 , R 1 , R 2 , R 3 , R 4 , and R N have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.

  该发明提供了具有一般式(I)的化合物及其药学上可接受的盐，其中变量RA、下标n、环A、X2、L、下标m、X1、R1、R2、R3、R4和RN的含义如本文所述，以及包含这种化合物的组合物和使用这种化合物和组合物的方法。
• DE521033
  申请人：——

  公开号：——

  公开（公告）日：——